采用群体药代动力学方法评估儿科重症监护患者万古霉素剂量以达到24小时AUC/MIC≥400
该前瞻性群体药代动力学研究纳入302例90天至<18岁的PICU患儿,中位年龄6.0岁,每例患者中位采集4次万古霉素血清浓度,随访至首次给药后7天。采用二室模型描述药代动力学,典型20 kg患者清除率为2.76 L/hr;床旁Schwartz方程或CKD-EPI公式估算的肾小球滤过率是清除率的唯一显著预测因子,两者预测性能相当。MIC=1 μg/mL时,达到AUC24/MIC=400的谷浓度为5.6-10.0 μg/mL。常规剂量15 mg/kg q6h和q8h达到AUC24/MIC≥400的比例分别为60.4%和36.5%。
要点
- 在PICU患儿中,万古霉素清除率的唯一显著预测因子是估算肾小球滤过率(eGFR),床旁Schwartz方程与CKD-EPI公式预测性能相当。
- MIC=1 μg/mL时,达到AUC24/MIC=400的谷浓度范围为5.6-10.0 μg/mL,谷浓度可准确预测AUC24。
- 常规剂量15 mg/kg q6h和q8h达到AUC24/MIC≥400的比例分别为60.4%和36.5%,q8h方案达标率较低。
- 该研究纳入的是未接受体外治疗的PICU患儿,中位年龄6.0岁,每例中位采集4次万古霉素血清浓度。
适用人群与场景
- 90天至<18岁、在四级护理PICU接受静脉万古霉素治疗的患儿,无论适应症。
- 研究纳入的是未接受体外治疗的PICU患者。
诊断标准与关键阈值
- 目标为万古霉素24小时AUC/MIC比值≥400。
- MIC=1 μg/mL时,达到AUC24/MIC=400的谷浓度范围为5.6-10.0 μg/mL。
处置流程与药物剂量
- 万古霉素由治疗临床医生选择剂量和间隔。
- 常规剂量15 mg/kg q6h和q8h达到AUC24/MIC≥400的比例分别为60.4%和36.5%。
研究设计与关键结果
- 前瞻性群体药代动力学研究,纳入302例PICU患儿,中位年龄6.0岁,每例中位采集4次万古霉素血清浓度,随访至首次给药后7天。
- 二室模型描述万古霉素药代动力学,典型20 kg患者清除率为2.76 L/hr。
- 床旁Schwartz方程或CKD-EPI公式估算的肾小球滤过率是清除率的唯一显著预测因子,两者预测性能相当。
- MIC=1 μg/mL时,达到AUC24/MIC=400的谷浓度为5.6-10.0 μg/mL。
- 常规剂量15 mg/kg q6h和q8h达到AUC24/MIC≥400的比例分别为60.4%和36.5%。
证据类型、等级与局限
- 证据类型:前瞻性群体药代动力学研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在PICU患儿中,万古霉素药代动力学仅依赖估算肾小球滤过率,谷浓度可准确预测AUC24。
- 常规剂量15 mg/kg q6h和q8h常导致AUC24/MIC低于400,尤其是q8h方案。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: To investigate which independent factor(s) have an impact on the pharmacokinetics of vancomycin in critically ill children, develop an equation to predict the 24-hour area under the concentration-time curve from a trough concentration, and evaluate dosing regimens likely to achieve a 24-hour area under the concentration-time curve to minimum inhibitory concentration ratio (AUC24/MIC) greater than or equal to 400.
DESIGN: Prospective population pharmacokinetic study of vancomycin.
SETTING: Critically ill patients in quaternary care PICUs.
PATIENTS: Children 90 days old or older to younger than 18 years who received IV vancomycin treatment, irrespective of the indication for use, in the ICUs at the University of Maryland Children's Hospital and Texas Children's Hospital were enrolled.
INTERVENTIONS: Vancomycin was prescribed at doses and intervals chosen by the treating clinicians.
MEASUREMENTS AND MAIN RESULTS: A median of four serum levels of vancomycin per patient were collected along with other variables for up to 7 days following the first administration. These data were used to characterize vancomycin pharmacokinetics and evaluate the factors affecting the variability in achieving AUC24/MIC ratio greater than or equal to 400 in PICU patients who are not on extracorporeal therapy. A total of 302 children with a median age of 6.0 years were enrolled. A two-compartment model described the pharmacokinetics of vancomycin with the clearance of 2.76 L/hr for a typical patient weighing 20 kg. The glomerular filtration rate estimated using either the bedside Schwartz equation or the chronic kidney disease in children equation was the only statistically significant predictor of clearance among the variables evaluated, exhibiting equal predictive performance. The trough levels achieving AUC24/MIC = 400 were 5.6-10.0 μg/mL when MIC = 1 μg/mL. The target of AUC24/MIC greater than or equal to 400 was achieved in 60.4% and 36.5% with the typical dosing regimens of 15 mg/kg every 6 and 8 hours (q6h and q8h), respectively.
CONCLUSIONS: The pharmacokinetics of vancomycin in critically ill children were dependent on the estimated glomerular filtration rate only. Trough concentrations accurately predict AUC24. Typical pediatric vancomycin dosing regimens of 15 mg/kg q6h and q8h will often lead to AUC24/MIC under 400.
参考来源
- Jung D, Kishk OA, Bhutta AT, et al. Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients. Crit Care Explor. 2024. PMID: 39352409. doi:10.1097/CCE.0000000000001159
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。